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Introduction 
Despite advances in medical treatment, and improvements in public health, myocardial ischaemia 
and infarction remain common causes of hospital admission worldwide (Nabel and Braunwald, 
2012).   The most common cause is coronary heart disease (CHD), a condition in which the coronary 
arteries supplying blood to the heart muscle are narrowed or blocked (Marshall, 2011).  In the UK, 
CHD consumes a large part of the NHS budget, and is the cause of death in 15% of men, and 10% of 
women (British Heart Foundation, 2015).  Although mortality rates have fallen over the past four 
decades, prevalence of the disease is rising, and increasing numbers of patients are seen in both 
primary and secondary care (Bhatnagar et al, 2015).   
Given the scale of the problem, the diagnosis and management of CHD is a priority in all healthcare 
settings (National Institute of Health and Care Excellence (NICE), 2010).  The 12-lead ECG plays an 
important role in this process, and is especially important in the diagnosis of acute ischaemic events 
(Hampton, 2013).  Changes in the QRS complex, ST-segment, and T-wave occur during ischaemia, 
and are combined with patient history and blood results when making a diagnosis (Houghton and 
Gray, 2014).  Of particular importance is the identification of persistent ST segment elevation, which 
has the strongest association with acute myocardial infarction (MI) (Thygesen et al, 2012).   
In this eighth instalment of our ECG series, we examine the ECG changes that occur during 
myocardial ischaemia and infarction, and place them in the context of underlying pathophysiology 
and clinical management.  Because of the size of the subject, we will address it in two parts.  In this 
first part we examine the coronary circulation, the pathophysiology of CHD, and the diagnosis and 
treatment of ST elevation MI (STEMI).  In the second part, to be published next month, we will 
complete our discussion of STEMI, before moving on to non-ST elevation MI (NSTEMI) and unstable 
angina.   
 
The coronary circulation 
Every cell in the human body requires oxygen to maintain its normal function (Marieb and Hoehn, 
2015).  Although many cells can function for brief periods without oxygen, a sustained loss of blood 
supply results in cellular dysfunction and ultimately cell death (Pappano and Wier, 2014).  The heart 
is especially vulnerable to ischaemia, having a high demand for oxygen, and a poor capacity for 
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anaerobic metabolism (Ramanathan and Skinner, 2005).  To meet its high demand for blood flow, 
the heart has a dedicated supply in the form of the coronary circulation (Kim et al, 2006). 
The coronary circulation consists of a branching network of arteries, veins and capillaries (Grech, 
2011).  The left and right coronary arteries arise from the base of the aorta, just above the aortic 
valve, and run across the epicardial surface of the heart in the first part of their course (Marieb and 
Hoehn, 2015) (Figure 1).  Both arteries give off important branches that also run on the outer surface 
of the heart, with smaller sub-branches diving down into the myocardium to feed an extensive 
capillary network (Tortora and Nielsen, 2014).  A network of cardiac veins returns blood to the right 
atrium, via the coronary sinus (Pappano and Wier, 2013).   
 
 
Figure 1. Typical coronary artery anatomy 
 
The right coronary artery (RCA) runs in the groove between the right atrium (RA) and right ventricle 
(RV), before coursing down the right side of the heart towards the apex (Tortora and Nielsen, 2014).  
It gives off important branches including the sinus node, RV and acute marginal branches (Kim et al, 
2006).  In most people it also gives rise to the posterior descending artery (PDA), which supplies the 
inferior wall of the left ventricle (LV) (Cademartiri et al, 2008).  Broadly speaking, the RCA supplies 
blood to the RA, RV, proximal conduction system, and inferior LV (Jowett and Thompson, 2007).  
Occlusion of the RCA is associated with inferior MI, often with RV involvement (Ondrus et al, 2013).  
Because the RCA supplies the proximal conduction system, AV block is common in this type of MI 
(Aehlert, 2011).  
The left coronary artery (LCA) runs in the left atrioventricular groove (Marieb and Hoehn, 2015).  
Following a short initial section referred to as the left main stem (LMS), the artery divides to form 
the left anterior descending (LAD) and left circumflex (LCx) arteries (Cademartiri et al, 2008).   The 
LAD runs down the front of the heart, giving off diagonal branches that supply the anterior wall of 
the LV, as well as perforators that penetrate and supply the interventricular septum (Tortora and 
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Nielsen, 2014).  Of the three major coronary arteries, the LAD provides the greatest proportion of 
blood to the LV (Rinta-Kiikka et al, 2014).  Blockage of this vessel therefore has the greatest effect on 
LV function, and is associated with increased morbidity and mortality (Lee et al, 1995).  The LCx 
continues around the left side of the heart in the atrioventricular groove (Marieb and Hoehn, 2015).  
Its major branches are the obtuse marginals, which supply blood to the lateral wall of the LV 
(Cademartiri et al, 2008).  It also supplies the left atrium (LA) and posterior wall of the LV (Kim et al, 
2006).   The relationship between coronary arteries and cardiac territory is summarised in table 1.     
 
Coronary artery Area of the heart supplied 
Right coronary artery (RCA) RA, RV, sinus node, AV node, inferior LV. 
Left anterior descending (LAD) Anterior LV, apex, interventricular septum 
Left circumflex (LCx) LA, lateral LV, posterior LV 
Table 1.  Areas of the heart typically supplied by each coronary artery 
 
Individual variation 
Although the arrangement described above is common, there can be significant variation in the 
branching pattern of the coronary circulation (Marieb and Hoehn, 2015).  In one third of people, the 
LCA trifurcates after the LMS to form three major branches instead of two (Rinta-Kiikka et al, 2014).  
The additional artery is referred to as the ramus intermedius, and supplies an area equivalent to the 
first diagonal branch (Jowett and Thompson, 2007).  Other people are born with a single coronary 
artery supplying the entire heart, or have arteries with highly unusual origins or courses (Cademartiri 
et al, 2008).   
A second area of variation is in collateral circulation.  Collaterals are vessels that link coronary 
arteries together via anastomoses, helping to improve blood supply across the heart (Tortora and 
Nielsen, 2014).  A growth in collateral circulation is seen in people who exercise regularly, and also in 
individuals with chronic CHD (Klabunde, 2012).  Research suggests that one in four people with CHD 
has sufficient collateral circulation to prevent ischaemia during brief coronary artery occlusion (Seiler 
et al, 2013).  This has a protective effect during acute ischaemic events, and is associated with 
decreased morbidity and increased survival (Regieli et al, 2009).   
This variation in coronary anatomy means that there is not always a direct relationship between ECG 
findings and the location of ischaemic events in the heart (Rinta-Kiikka et al, 2014).  One of the most 
important confounders to be aware of is the source of the PDA, and therefore the blood supply to 
the inferior LV (Jowett and Thompson, 2007).  In 85% of people, the circulation is said to be right 
dominant, meaning that the PDA arises from the RCA (Kim et al, 2006).  In these people, an inferior 
MI is the result of RCA occlusion (Hampton, 2013).  In contrast, 7-8% of people have a left dominant 
circulation, in which the PDA arises from the LCx, making this the likely culprit vessel during inferior 
MI (Houghton and Gray, 2014).  In the remaining 7-8% of the population, the coronary circulation is 
co-dominant; the inferior LV is perfused by branches arising from both the RCA and the LCx (Rinta-
Kiikka et al, 2014).   
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Pathophysiology of coronary heart disease 
As with all arteries, those in the coronary 
circulation are composed of three layers; an 
outer ‘tunica adventitia’, a middle ‘tunica 
media’ and an inner ‘tunica intima’ (Marieb and 
Hoehn, 2015) (figure 2).  The adventitia is 
composed of tough connective tissue, the 
media of smooth muscle cells, and the intima of 
endothelial cells (Tortora and Nielsen, 2014).   
When the demand for blood flow is high, for 
example during exertion, the smooth muscle in 
the media relaxes, dilating the vessel lumen and 
increasing blood flow (Marieb and Hoehn, 
2015).  This process is regulated by the release 
of vasoactive hormones from the endothelial 
cells of the intima (Ramanathan and Skinner, 
2005).  The endothelial lining also provides a 
smooth, non-stick surface to the inside of the 
artery, promoting blood flow and resisting the 
adhesion of white blood cells (Libby et al, 2011).   
 
 
 
Figure 2.  Arterial wall layers 
 
CHD occurs when the endothelial lining of the coronary artery becomes damaged by oxidative, 
haemodynamic or biochemical processes (Nabel and Braunwald, 2012).  Common causes of damage 
include cigarette smoking, hypertension and high levels of glucose or cholesterol in the blood (Yusef 
et al, 2004).  Further risk factors for CHD development are detailed in box 1.  Damage to the 
endothelium triggers a chronic inflammatory process in which white blood cells and lipids 
accumulate in the intimal layer of the artery wall (Libby et al, 2011).  Over time, the lesion is swelled 
by the migration of smooth muscle cells from the media, and the formation of a fibrous cap (Stone 
et al, 2011). 
 
Modifiable risk factors Non-modifiable risk factors 
Smoking 
Alcohol intake 
Lack of physical exercise 
Low consumption of fruits and vegetables 
Hypertension 
Hypercholesterolaemia 
Diabetes 
Abdominal obesity 
Psychosocial factors 
Age 
Male gender 
Family history of premature CHD 
Ethnicity 
Box 1. Risk factors for coronary artery disease (Kennedy 2008) 
 
As the lesion grows, the lumen of the vessel becomes progressively narrower, although significant 
impairment of blood flow may not occur until 60 to 70% of the lumen is obstructed (Gould, 2009).  
At this point, ischaemia may occur during increased demand, resulting in predictable, exertional 
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symptoms described as stable angina (Grech, 2011).  The classical symptom of stable angina is 
retrosternal chest pain that is provoked by exertion, and relieved by rest or short-acting nitrates 
(Nabel and Braunwald, 2012).   The pain is often described in terms of pressure, tightness or weight 
on the chest, and may radiate to the shoulders, neck, jaw, back or arms (Fox et al, 2006).  It is rarely 
severe, and usually does not last more than 15 minutes (NICE, 2010).  If there is a well-developed 
collateral circulation, individuals may have few or no symptoms despite high grade stenosis or even 
complete vessel occlusion (Seiler et al, 2013).   
In contrast, unpredictable or severe symptoms are usually related to sudden rupture of the cap 
covering a lesion (Marshall, 2009).  This exposes the lipid rich contents to the circulating blood, 
triggering platelet aggregation, blood clot formation, and vasoconstriction (Libby et al, 2011) (figure 
3).  This may completely or partially occlude the vessel, resulting in severe ischaemia or infarction of 
the area supplied by the artery (Steg et al, 2012).  These sudden and life threatening thrombotic 
events are described as acute coronary syndromes (ACS) (Arbab-Zadeh et al, 2012).  Unlike stable 
angina, ACS is typified by chest pain that is persistent, unrelieved by rest or nitrates, and often 
associated with nausea, vomiting and sweating (NICE, 2010).  ACS is a medical emergency, 
warranting emergency assessment and treatment (Marshal, 2009).   
 
 
Figure 3.  Rupture of the cap covering an atherosclerotic lesion, resulting in platelet 
aggregation and blood clot formation (adapted from Libby et al, 2011). 
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The 12 lead ECG in ACS 
During the early minutes of an ACS, the 12-lead ECG may be entirely normal despite severe 
symptoms (Morris and Brady, 2009).  Serial ECGs should therefore be performed, ideally at 15-30 
minute intervals, or using continuous computer-assisted recording (Thygesen et al, 2012).  Serial 
ECGs will also capture dynamic changes, providing information about the timing of events, the 
affected artery, the amount of myocardium at risk, and potential treatment strategy (Steg et al, 
2012).  Where possible, comparison should be made with previous ECGs as prior ischaemic events, 
or chronic changes, may confound diagnosis (Houghton and Gray, 2014). ECG evaluation should also 
be made in the light of patient history, physical examination, and the level of biochemical markers, 
ideally troponin I or T (Hampton, 2013).   
Depending on the findings of clinical evaluation, ACS can be classified as one of the following: 
 ST elevation MI (STEMI) 
 Non-ST elevation MI (NSTEMI) 
 Unstable angina 
At initial presentation, the focus is on confirming or excluding the presence of STEMI because 
current treatment guidelines recommend immediate reperfusion therapy in these patients (NICE, 
2013; Steg et al, 2012).  Troponin levels are not needed to initiate treatment in STEMI, although they 
are essential to the management of NSTEMI and unstable angina (Marshall, 2011). 
 
ST elevation MI 
STEMI results from the acute occlusion of an epicardial coronary artery, and is associated with 
transmural ischaemia of a significant area of the heart (Wei et al, 2013).  If ischaemia is not relieved, 
infarction of the affected area may ensue within an hour, with progressive tissue damage as further 
time elapses (Rinta-Kiikka et al, 2014).  Early identification of STEMI, and reperfusion of the affected 
area, limits infarction size and decreases complications and mortality (McNamara et al, 2006).   
STEMI can be identified by a patient history of typical symptoms, in association with ST elevation in 
at least two anatomically contiguous leads, in other words two ECG leads looking at the same area of 
the heart (Steg et al, 2012).  For the purpose of contiguous leads, the ECG can be divided into three 
groups of leads, each of which corresponds approximately with an anatomical region, and the blood 
supply from a major coronary artery (Morris and Brady, 2009) (table 2).   
 
ECG leads Anatomical area Probable culprit artery 
II, III, aVF Inferior LV wall Right coronary artery 
V1-V4 Anterior LV wall Left anterior descending 
I, aVL, V5, V6 Lateral LV wall Left circumflex 
Table 2.  Contiguous leads in STEMI diagnosis.  Probable culprit artery is based on a typical right 
dominant circulation. 
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Although ST elevation is the key diagnostic feature in STEMI, a number of associated ECG changes 
are commonly seen (Hampton, 2013).  These appear in a sequential fashion, creating a dynamic ECG 
pattern that is characteristic of STEMI (Thygesen et al, 2012).  These dynamic changes help to 
differentiate STEMI from other causes of chest pain, although not every feature is seen in every 
patient (Houghton and Gray, 2014).  Typical features include (Garcia, 2015) (figure 4) 
 Hyperacute T-waves 
 ST segment elevation 
 Q-wave formation 
 Loss of R-wave height 
 T-wave inversion 
 Reciprocal ST segment depression  
Let’s examine each of these changes in turn.  
 
 
Figure 4.  Evolution of a STEMI 
 
Hyperacute T-waves 
Hyperacute T-waves are the first ECG sign of an evolving STEMI, and appear within five to thirty 
minutes of artery occlusion (Morris and Brady, 2009) (figure 4).  Because of the time that usually 
elapses between symptom onset and the recording of an ECG, they may not be seen, making ST 
elevation the first detected ECG change (Houghton and Gray, 2014).  Hyperacute T-waves are taller, 
more symmetrical, and more peaked than normal (Garcia, 2015).  They appear in the ECG leads 
overlying the ischaemic area of the heart, and tend to be more prominent in the chest leads 
(Hampton, 2013).  Comparison with previous ECGs may be needed to confirm their presence (Morris 
and Brady, 2009).   
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ST segment elevation 
The ST segment is the short section of baseline that joins the end of the QRS complex to the T-wave 
(figure 5).  This segment is normally isoelectric, meaning that it is at the same level as the TP 
segment (Aehlert, 2011).  Elevation of the ST segment follows hyperacute T-waves in the evolution 
of STEMI, and occurs within the first few hours of ischaemia (Houghton and Gray, 2014) (figure 6).  
The initial rise may be small, however a progressive increase in the height of the ST segment often 
occurs (Garcia, 2015).  The ST segment may merge with the T-wave, with complete loss of the ST-T 
angle (Morris and Brady, 2009).  If the ST segment reaches the top of the QRS as well, a single 
monophasic waveform results, commonly referred to as a ‘tombstone’ (Hampton, 2013).  Figure 7 
illustrates different degrees of ST elevation.        
 
 
Figure 5. The ST segment (in red) starts at the J point, and is isoelectric with the TP segment. 
 
 
 
Figure 6.  Inferior STEMI.  There is > 1mm of ST elevation in leads II, III and aVF.  The ST depression 
in lead aVL is a reciprocal change.   
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Figure 7. Degrees of ST elevation.  In the right hand example, the ST segment has almost entirely 
merged with the QRS and T-wave to form a single ‘tombstone’ complex. 
 
ST segment elevation is measured at the J-point (Houghton and Gray, 2014).  This is the point where 
the QRS complex transitions into the ST segment (figure 5).  Elevation of the J point is a normal 
variant in leads V2 and V3, especially in young men (Hampton, 2013).  This phenomenon is often 
referred to as ‘high take-off’ or an ‘early repolarisation pattern’ (Garcia, 2015) (figure 8).  The degree 
of ST elevation required to diagnose STEMI is therefore greater in these leads, and greater in men 
than women (Thygesen et al, 2012) (table 3).   
 
 
Figure 8.  High take off in leads V2 and V3.  The patient was a fit and healthy young man attending 
for routine health screening.  There is isolated T-wave inversion in lead III, which is normal variant. 
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ECG leads Population ST elevation considered 
diagnostic 
All leads except V2/V3 All patients ≥ 1 mm 
V2/V3 Women ≥ 1.5 mm 
V2/V3 Men ≥ 40 years old ≥ 2 mm 
V2/V3 Men < 40 years old ≥ 2.5 mm 
Table 3.  Degree of ST elevation needed to diagnose STEMI in the standard ECG leads.  Assumes 
normal calibration of the ECG (10mm = 1mV), and the absence of LVH or LBBB. 
 
Q-wave formation and loss of R-wave height 
A Q-wave refers to any downward deflection preceding an R-wave (Aehlert, 2011).  Small, narrow Q-
waves are a normal finding in the leads facing the LV, and reflect left to right depolarisation of the 
interventricular septum (Hampton, 2013).  These ‘septal Q-waves’ are normally seen in leads I, aVL, 
aVF, V4, V5 and V6 (Thygesen et al, 2012) (figure 9).  A Q-wave is also a normal finding in lead aVR, 
and is a normal variant in leads V1 and III (Houghton and Gray, 2014).   
 
 
Figure 9.  Septal Q-waves.  There are small, narrow Q-waves in leads I, II, aVL, aVF, V4-V6.   
 
Abnormal, or pathological, Q-waves may develop as a STEMI evolves, and usually appear while the 
ST segment is still elevated (Houghton and Gray, 2014).  They are caused by a loss of viable 
myocardium below the recording electrode, and are therefore a marker of tissue necrosis (Garcia, 
2015).  They are often accompanied by a loss of R-wave height in the same leads (Aehlert, 2011) 
(Figure 10).  The explanation for Q-wave appearance is simple.  Infarcted myocardium is electrically 
inert – it does not produce electricity, and is therefore invisible to the ECG (Hampton, 2013).  An ECG 
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electrode placed over an area of dead tissue therefore ‘sees’ through the infarcted area to the 
healthy wall on the opposite side of the heart.  Because depolarisation starts at the endocardium 
and moves outwards through the heart wall, the electrical vector that the lead sees is moving away 
from it, and therefore a negative deflection is recorded (Jowett and Thompson, 2007).     
The timing of pathological Q-wave formation is variable; it may occur within the first few hours, or 
not until 24 hours have elapsed (Morris and Brady, 2009).  Because of this, Q-wave development 
does not accurately predict the timing of ischaemic events, nor does it indicate a completed MI 
(Marshall, 2009).  Q-waves often persist as a permanent marker of MI, although in smaller infarcts 
contraction of scar tissue during healing can result in their disappearance (Rinta-Kiikka et al, 2014).   
Pathological Q-waves are usually wide and/or deep, and may occur in leads where Q-waves are not 
normally seen (Marshall, 2009).  Houghton and Gray (2014) suggest that the features of abnormal Q-
waves are 
 Width > 1 small square, and/or 
 Depth >2 small squares / > 25% of the subsequent R-wave height 
 
 
 
Figure 10. Anterior STEMI.  Note the ST elevation in leads V1-V6, and deep, wide Q-waves in leads 
V1-V4.   
 
T-wave inversion 
With further evolution of the STEMI, the ST segment starts to return towards baseline, and the T-
waves begin to invert (Garcia, 2015) (figure 11).  It may take several weeks for the ST segment to 
completely normalise; T-wave inversion may persist for months, or even remain as a permanent 
marker of infarction (Morris and Brady, 2009).  Persistent ST elevation is suggestive of an LV 
aneurysm, although it is not a reliable indicator (Hampton, 2013) (figure 12).  Houghton and Gray 
(2014) suggest that this late complication of MI occurs in around 10% of survivors.   
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Figure 11.  The same patient as figure 10, following primary PCI.  The ST segments are returning 
towards baseline and the T-waves are inverting.  
 
 
 
Figure 12.  The same patient, 12 months post MI.  The ST segments are still slightly elevated.  
Echocardiography excluded LV aneurysm.  Note the Q-waves, loss of R-wave height and inverted T-
waves.  
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Reciprocal ST depression 
Reciprocal ST depression refers to changes that are seen in leads remote from the region of the 
infarct (Houghton and Gray, 2014) (figure 6).  It is often described as a ‘mirror image’ change, in 
other words the ST depression seen reflects ST elevation occurring on the other side of the heart 
(Garcia, 2015).  Reciprocal ST depression is seen in around 70% of inferior STEMI, and 30% of 
anterior (Morris and Brady, 2009).  It has a high positive predictive value for STEMI, and is therefore 
useful in supporting a diagnosis when ECG features or symptoms are atypical (Hampton, 2013).   
The cause of reciprocal ST depression is uncertain; it may represent ischaemia remote from the site 
of the infarction, or be a benign electrical phenomenon (Morris and Brady, 2009).  Recent research 
suggests that persistent reciprocal ST depression after STEMI is associated with increased infarct 
size, and a higher risk of adverse cardiovascular events in the future (Reinstadler et al, 2015). 
 
Treatment of STEMI 
The treatment priority for patients presenting with STEMI is to re-open the occluded artery, and 
reperfuse the ischaemic area of the heart (Steg et al, 2012).  One half of potentially salvageable 
tissue may be lost within the first hour of ischaemia, and two thirds by three hours (Reimer et al, 
1977).  Time is therefore of the essence (Lassen et al, 2013).  Reperfusion can be achieved by one of 
two methods; thrombolysis or primary percutaneous coronary intervention (PCI) (Jowett and 
Thompson, 2007).   
Thrombolysis uses intravenous drugs to dissolve the clot blocking the artery, and was the treatment 
of choice in the 1980s and early 1990s (Nabel and Braunwald, 2012).  Although thrombolysis 
improves outcomes in most patients, it is unsuccessful in 20-30% of cases (Department of Health 
(DH), 2008).  It is also associated with a risk of acute bleeding, and causes haemorrhagic stroke in 1% 
of recipients (NICE, 2013).  It can, however, be administered rapidly in any healthcare setting, 
including local healthcare facilities or the back of an ambulance (Gershlick et al, 2013).  It may be the 
only viable option in remote locations with poor access to a large hospital (Redberg, 2012). 
In contrast, PCI requires admission to a hospital equipped and staffed to perform cardiac 
catheterisation (Nabel and Braunwald, 2012).   This limits treatment to specialised centres, usually 
located in large, regional hospitals (DH, 2008).  Coronary angiography is performed to identify the 
blocked artery, and balloon angioplasty to re-open it (Cooper, 2015).  A stent is usually deployed to 
prevent re-occlusion (Stefanini and Holmes 2013).  Other techniques such as clot aspiration may also 
be used to maximise vessel patency, and to minimise complications such as downstream 
embolization of micro-emboli (Lam, 2015).  PCI is associated with fewer complications than 
thrombolysis, and improved outcomes provided it is delivered in a timely fashion (Asseburg et al, 
2007).   
The speed with which reperfusion can be delivered is the key discriminator in deciding between 
thrombolysis and PCI (Gershlick et al, 2013).  Current national guidance recommends PCI if it can be 
delivered within 120 minutes of when thrombolysis could be given (NICE, 2013).  If the delay is likely 
to be greater than 120 minutes, thrombolysis is the preferred option.  There are several caveats to 
this guidance.  Firstly, PCI is recommended in patients with cardiogenic shock, even if treatment 
delay is likely to exceed two hours.  Secondly, the guidance only applies if the patient has presented 
within 12 hours of symptom onset.  If presentation is later than this, PCI is not recommended unless 
there is evidence of ongoing ischaemia (NICE, 2013).  This recommendation is based on research, 
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including the large Occluded Artery Trial, that failed to show a benefit of delayed PCI compared to 
medical treatment (Hochman et al, 2006).  National audit data for England in 2013-14 shows that 
98.5% of eligible STEMI patients received PCI, and only 1.5% thrombolysis (Myocardial Ischaemia 
National Audit Project, 2014).   Other acute interventions for STEMI are listed in table 4, however 
their delivery should not delay reperfusion (NICE, 2010).   
 
Intervention Rationale / notes 
Aspirin 300mg orally To inhibit further platelet aggregation 
Sublingual or buccal nitrates (e.g. GTN spray) and 
intravenous opiates (usually morphine) 
To relieve pain and reduce cardiac work; pain 
increases sympathetic tone, making the heart 
work harder and use more oxygen. 
Intravenous anti-emetic To relieve nausea and vomiting, which is a 
common side effect of opiates, as well as a 
common symptom of STEMI. 
Supplemental oxygen, if indicated. Only if SpO2 falls below 94%.  Target SpO2 is  
 94-98% in most adults 
 88-92% in people with chronic obstructive 
pulmonary disease, when there is a risk of 
hypercapnic respiratory failure  
Continuous monitoring of ECG and vital signs To detect hypoxia, hypotension and arrhythmias.  
Hypotension may result from STEMI, or the 
administration of nitrates / opiates.  Arrhythmias 
are common in acute STEMI, especially AV blocks 
and VT/VF, and may be life threatening.  
Serial ECGs To detect dynamic ECG changes 
Emergency pacing / defibrillation Should be available in the event of life 
threatening arrhythmia. 
Information and reassurance STEMI is a frightening experience for both 
patient and relatives.  Simple information giving 
and appropriate reassurance can reduce anxiety. 
Table 4.  Interventions during acute STEMI (NICE, 2010; Steg et al, 2012) 
 
Conclusion 
Although ACS presents in a variety of ways, persistent ST elevation has the strongest association 
with acute myocardial infarction, and is an indication for emergency reperfusion (Steg et al, 2012).  
During a STEMI, various ECG changes may be seen, including hyperacute T-waves, ST segment 
elevation, pathological Q-waves, loss of R-wave height, and T-wave inversion (Houghton and Gray, 
2014).  These progressive changes are seen in contiguous leads, and provide information about the 
location of the infarct, its progress, and the area of myocardium at risk (Thygesen et al, 2012).   
Although ECG changes during STEMI are characteristic, they must be correlated with patient history 
and physical examination in reaching a diagnosis (Hampton, 2013).  Care should also be taken to 
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exclude normal variants such as early repolarisation or septal Q-waves (Garcia, 2015).  Once 
diagnosis is confirmed, reperfusion by PCI is the preferred option, although thrombolysis is an 
alternative if a treatment delay of more than two hours is anticipated (NICE, 2013).   Aspirin, 
analgesia and continuous monitoring are also important while reperfusion is arranged, but should 
not delay definitive treatment (NICE, 2010).   
 
Next month 
Despite the usefulness of the ECG in the diagnosis of STEMI, it does have some weaknesses (Steg et 
al, 2012).  Firstly, there are a number of non-ischaemic conditions that produce ST elevation on the 
ECG, some of which also cause chest pain (Houghton and Gray, 2014).  This can result in diagnostic 
uncertainty, or misdiagnosis (Edhouse et al, 2009).  Secondly, the right ventricle and posterior wall of 
the heart are not ‘seen’ by the standard ECG leads, making infarction of these regions harder to 
diagnose (Wei et al, 2013).  Additional ECG leads are often necessary (Garcia, 2015).  Thirdly, new 
left bundle branch block is a STEMI equivalent, and an indication for reperfusion (Thygesen et al, 
2012).  It may also be long standing problem with a non-ischaemic aetiology, making diagnosis 
problematic (Kumar et al, 2013).   
Next month, we complete our examination of STEMI by considering these difficulties.  We also turn 
our attention to the other two ACS presentations, NSTEMI and unstable angina, and consider the 
role of the ECG in their management. 
 
Key points 
 Acute coronary syndromes (ACS) are life threatening events associated with coronary artery 
lesion rupture and thrombus formation.  Symptoms include persistent chest pain that is not 
relieved by rest or nitrates, nausea and vomiting, and sweating. 
 
 ACS can be divided into STEMI, NSTEMI and unstable angina, according to ECG appearance and 
the result of biochemical markers such as troponin.  Persistent ST segment elevation has the 
strongest association with myocardial infarction, and is an indication for immediate thrombolysis 
or PCI.  Confirmation of troponin rise is not needed to initiate reperfusion in STEMI.  
 
 In the standard ECG leads, the diagnostic criteria for STEMI is ST elevation of 1mm or more in 
two contiguous ECG leads, although the cut-off is increased in leads V2 and V3.  The diagnostic 
level in these two leads depends on age and gender. 
 
 During STEMI, ST elevation is often accompanied by progressive change in the ECG that includes 
Q-wave formation, loss of R-wave height, and T-wave inversion.  Hyperacute T-waves may 
precede ST elevation, but are often not seen.  Dynamic change in the ECG strengthens the 
diagnostic certainty of STEMI, as does reciprocal ST depression. 
 
 Delay in achieving reperfusion is associated with larger infarct size and increased mortality.  
Current NICE guidance recommends PCI if it can be performed without excessive delay.  If the 
delay to treatment is likely to exceed two hours, thrombolysis should be considered instead. 
Additional treatment such as aspirin, analgesia and oxygen may be given, but should not delay 
reperfusion. Patients should be monitored for hypoxia, hypotension and arrhythmias.  
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